BORA PHARMACEUTICALS LTD (6472) — Financial Flexibility Index
BORA PHARMACEUTICALS LTD (6472) has a Financial Flexibility Index of 0.03x as of March 2026. Free cash flow of NT$779.54 Million (operating CF NT$568.46 Million minus capex NT$211.08 Million) represents 0% of total liabilities (NT$28.70 Billion). Check BORA PHARMACEUTICALS LTD asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BORA PHARMACEUTICALS LTD Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for BORA PHARMACEUTICALS LTD across 7 annual periods. See BORA PHARMACEUTICALS LTD current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BORA PHARMACEUTICALS LTD (2019–2025)
Year-by-year free cash flow to debt coverage for BORA PHARMACEUTICALS LTD. For the full company profile including market capitalisation, see BORA PHARMACEUTICALS LTD stock valuation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | NT$5.17 Billion | NT$4.24 Billion | NT$27.24 Billion | ▲ +248.1% |
| 2024 | 0.05x | NT$1.67 Billion | NT$980.81 Million | NT$30.59 Billion | ▼ -88.0% |
| 2023 | 0.45x | NT$6.04 Billion | NT$4.61 Billion | NT$13.29 Billion | ▲ +262.7% |
| 2022 | 0.13x | NT$2.21 Billion | NT$2.01 Billion | NT$17.62 Billion | ▼ -66.9% |
| 2021 | 0.38x | NT$1.60 Billion | NT$1.24 Billion | NT$4.22 Billion | ▲ +421.8% |
| 2020 | 0.07x | NT$329.88 Million | NT$177.79 Million | NT$4.54 Billion | ▼ -86.5% |
| 2019 | 0.54x | NT$929.10 Million | NT$231.77 Million | NT$1.73 Billion | — |